M10 inhibited RANKL and WNT5A expression in RA synoviocytes both in vivo and in vitro by downregulating the JAK-STAT3 pathway; at the same time, it ameliorated the arthritis in the CAIA mouse model in vivo. Here, STAT3 is linked to arthritic joint disease.